XML 50 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Other Related Charges
 12 Months Ended
Dec. 31, 2021
Restructuring and Related Activities [Abstract]  
Restructuring and Other Related Charges
NOTE 15. RESTRUCTURING AND OTHER RELATED CHARGES
Restructuring and other related charges for the years ended December 31 were as follows ($ in millions):
202120202019
Employee severance related$12.8 $21.1 $46.9 
Facility exit and other related5.9 5.7 3.5 
Total restructuring and other related charges$18.7 $26.8 $50.4 
Substantially all restructuring activities initiated in 2021 were completed by December 31, 2021. We expect substantially all cash payments associated with remaining termination benefits recorded in 2021 will be paid in 2022, and all planned restructuring activities related to the 2020 and 2019 plans have been completed.
The nature of our restructuring and related activities initiated in 2021, 2020 and 2019 were broadly consistent throughout our segments and focused on improvements in operational efficiency through targeted workforce reductions and facility consolidations and closures. We incurred these costs to position ourselves to provide superior products and services to our customers in a cost-efficient manner, while taking into consideration broad economic uncertainties, including those created by the COVID-19 pandemic.
Restructuring and other related charges recorded for the years ended December 31 by segment were as follows ($ in millions):
202120202019
Intelligent Operating Solutions$7.4 $12.5 $23.8 
Precision Technologies6.8 9.8 26.4 
Advanced Healthcare Solutions4.5 4.5 0.2 
Total$18.7 $26.8 $50.4 
The table below summarizes the accrual balance and utilization by type of restructuring cost associated with our 2021 and 2020 restructuring actions ($ in millions):
Balance
as of
January 1, 2020		Costs
Incurred		Paid/
Settled		Balance 
as of
December
31, 2020		Costs
Incurred		Paid/
Settled		Balance as of December 31, 2021
Employee severance and related$32.4 $21.1 $(38.7)$14.8 $12.8 $(17.5)$10.1 
Facility exit and other related0.2 5.7 (5.3)0.6 5.9 (5.8)0.7 
Total$32.6 $26.8 $(44.0)$15.4 $18.7 $(23.3)$10.8 
The restructuring and other related charges incurred during 2021, 2020, and 2019 were substantially all cash charges. These charges are reflected in the following captions in the Consolidated Statements of Earnings ($ in millions):
202120202019
Cost of sales$2.8 $8.2 $13.8 
Selling, general, and administrative expenses15.9 18.6 36.6 
Total$18.7 $26.8 $50.4